Mergon Group Acquired Inmo Tech Limited
The injection-molding specialist expanded its manufacturing capacity for medical device and healthcare components.
Updated on Oct. 6, 2026 in Healthcare
Live Poll
Do you believe local manufacturing benefits when smaller firms are acquired by larger global companies?
Mergon Group has finalized the acquisition of Enniscrone-based Inmo Tech Limited. This deal integrates Inmo Tech manufacturing facilities and personnel into the Mergon Group to expand healthcare production capabilities.
Why it matters
The acquisition allows Mergon to consolidate specialist injection-moulding expertise under its own brand. This move is designed to support existing major healthcare customers by scaling regional manufacturing footprints and technical capacity.
Mergon Group has integrated Inmo Tech Limited, a specialist manufacturer of precision injection-moulded components. Financial details regarding the deal size remain undisclosed.
The players
Mergon Group
An international manufacturing firm headquartered in Castlepollard that provides precision components to healthcare companies.
Inmo Tech Limited
A precision injection-moulding component manufacturer based in Enniscrone that primarily serves the healthcare sector.
Abbott
A global healthcare leader that sources precision components from suppliers like Mergon.
Beckman Coulter
A clinical diagnostics and life sciences provider that utilizes precision-moulded parts in its hardware.
Pfizer
A multinational pharmaceutical and biotechnology company that integrates components from specialized manufacturing vendors.
The details
Mergon Group will fold Inmo Tech existing manufacturing facilities and personnel into its broader organizational structure. By acquiring a firm with specific injection-moulding expertise, Mergon aims to strengthen its specialized healthcare component output. This expansion directly benefits Mergon's supply chain capacity for major healthcare clients including Abbott, Beckman Coulter, and Pfizer.
Timeline
October 6, 2026: Mergon announced the completion of the acquisition.
Market Landscape
This acquisition reflects the broader industry trend of vertical integration within the medical device manufacturing supply chain. Mergon is following an established strategy of consolidating specialized production sites to secure consistent quality for high-stakes healthcare clients.
Manufacturers should evaluate how this consolidation of specialist injection-moulding capacity impacts existing lead times and vendor qualification requirements. Watch for how Mergon leverages this new capability to potentially outpace smaller competitors in high-precision component bidding.
The takeaway
Healthcare suppliers are increasingly seeking internal technical expertise to mitigate supply chain risks for critical medical components. Operators should track whether this move signals a broader transition toward M&A as a primary method for acquiring specialized technical talent and facilities.
Further reading
For broader trends in medical manufacturing, visit our Healthcare sector analysis.
Source note: This article includes information reported by Westmeath Examiner.
Live Poll
Do you believe local manufacturing benefits when smaller firms are acquired by larger global companies?
